<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-042410</identifier>
<setSpec>0210-573X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Ovarian adenosarcoma with a heterologous component</dc:title>
<dc:description xml:lang="en">Mullerian adenosarcoma is a bifasic tumour composed of a benign glandular component, occasionally with atypical cells, associated with a malignant mesenchymal component. The sarcomatous portion of the adenosarcoma may vary from low to very high grade, and its clinical behavior may be inactive or aggressive. Generally they originate in the uterus. Extrauterine sites are infrequent, but may be in the ovaries, fallopian tubes or the peritoneal mesothelium. We describe a case of ovarian adenosarcoma with early pelvic recurrence, and review the literature (AU)</dc:description>
<dc:creator>López-Duque, J. C</dc:creator>
<dc:creator>Díez, J</dc:creator>
<dc:creator>Unamuno, M</dc:creator>
<dc:creator>Eizaguirre, B</dc:creator>
<dc:creator>Moreno, J</dc:creator>
<dc:creator>Ibáñez, E</dc:creator>
<dc:creator>Rodríguez-Escudero, F. J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El adenosarcoma mülleriano es un tumor bifásico constituido por un componente glandular benigno, ocasionalmente con atipias, asociado a un componente mesenquimal maligno. El adenosarcoma ovárico tiene un peor pronóstico que su homónimo uterino. En dos tercios de los casos se produce recidiva tumoral y casi siempre en los primeros 5 años tras el diagnóstico. En pacientes en estadio I, la edad menor a 53 años, la rotura tumoral, el alto grado y el sobrecrecimiento estromal se asocian a una alta tasa de recidiva. Presentamos un caso de adenosarcoma ovárico en estadio Ia diagnosticado en nuestro centro, con recidiva precoz, y revisamos la bibliografía (AU)</dc:description>
<dc:source>Clín. investig. ginecol. obstet. (Ed. impr.);32(2): 82-86, mar.-abr. 2005. ilus, tab</dc:source>
<dc:identifier>ibc-042410</dc:identifier>
<dc:title xml:lang="es">Adenosarcoma ovárico con componente heterólogo</dc:title>
<dc:subject>^d24339^s22045</dc:subject>
<dc:subject>^d31300^s22009</dc:subject>
<dc:subject>^d15000^s29166</dc:subject>
<dc:subject>^d11812</dc:subject>
<dc:subject>^d22921^s22045</dc:subject>
<dc:subject>^d31673^s22016</dc:subject>
<dc:subject>^d31300^s22016</dc:subject>
<dc:subject>^d9557</dc:subject>
<dc:subject>^d23568^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d7991^s22045</dc:subject>
<dc:subject>^d7225^s22045</dc:subject>
<dc:subject>^d14995^s22016</dc:subject>
<dc:subject>^d15000^s22009</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d15000^s22053</dc:subject>
<dc:subject>^d31673^s22012</dc:subject>
<dc:subject>^d35089</dc:subject>
<dc:subject>^d14995^s22009</dc:subject>
<dc:type>article</dc:type>
<dc:date>200504</dc:date>
</metadata>
</record>
</ibecs-document>
